In this episode, we welcome Dr. Michaël Baboudjian from Marseille, France, to discuss the topic of Active Surveillance for prostate cancer.

Discover:

• The principles of active surveillance

• The key elements of an effective surveillance strategy

• The collaboration between radiologists and urologists

• The criteria for selecting patients eligible for active surveillance

• Finding the right balance between under- and overtreatment

Hosted by Ausha. See ausha.co/privacy-policy for more information.

We are with Dr Jonathan Fainberg, from the USA. He shares his experience with focal therapies, and offers advice for physicians.

Discover:

• The importance of MRI in the diagnosis and treatment of prostate cancer

• The different energy sources used in focal therapy

• The patient's role in their care journey

• A new perspective on prostate cancer management

Hosted by Ausha. See ausha.co/privacy-policy for more information.

Dr Miñana, from Spain, talks about Focal Therapy, but more specilfically , the importance of fusion system and MRI images in the treatment of Prostate Cancer.

Let's talk about:

• The hot topics in prostate care

• The advantages of focal therapies

• The impact of MRI images in the treatment of prostate cancer

Hosted by Ausha. See ausha.co/privacy-policy for more information.

In this episode, Dr Samuel Yee, from Hong-Kong, discusses:

• How treatment choices depend on the patient

• The importance of imaging quality in treatment planning

• The use of rectal spacer in Focal Therapy

• A spacial focus on cryotherapy

Hosted by Ausha. See ausha.co/privacy-policy for more information.

The question of choosing between transrectal and transperineal biopsies often arises for prostate biopsies. Dr Louis Lenfant, France, gives us his opinion in this new episode.

Discover:

• The patient centric approach

• The switch from transrectal to transperineal prostate biopsy

• The indispensable tips and tricks to perform prostate biopsies

Hosted by Ausha. See ausha.co/privacy-policy for more information.

This episode is an interview of Dr Miriam Traumann, from Germany. We talk about the role of data in prostate care management.

Here are the main topics discussed:

• Data collection in fusion biopsy

• How to use these data

• How the data led here to perform transperineal targeted biopsies

• The learning curve for transperineal biopsies

• The future of prostate care

• The place of women urologists in a predominantly male environment

Hosted by Ausha. See ausha.co/privacy-policy for more information.

In this episode, we talk with Dr Karsten Günzel from Germany about Artificial Intelligence in prostate care management.

Here is a sneak peak of what to expect:

• The importance of image quality

• The collaboration between urologist and radiologist

• The contribution of AI for biopsy planning

• The impact of AI on the urologist's daily routine

Hosted by Ausha. See ausha.co/privacy-policy for more information.

In this new episode, we welcome Dr Peter Chiu from Hong-Kong to talk about another topic than prostate cancer: BPH

Discover:

• What is BPH and its symptoms

• Treament options

• Targeted microwave ablation for BPH

• Initial results on the study testing TMA for BPH

• Patients' feedbacks

Hosted by Ausha. See ausha.co/privacy-policy for more information.

In this episode, we have the pleasure to welcome Prof Roman Ganzer, from Asklepios Hospital Bad Tölz, Germany. Together, we will explore the different focal therapies available on the market.

At the agenda:

Which focal treatments is Prof Ganzer offering, and why?

What are his advises if you want to perform focal therapies?

What is the situation in Germany and Europe?

Hosted by Ausha. See ausha.co/privacy-policy for more information.

In this episode, we have the pleasure to interview Prof Romain Diamand, from Institut Jules Bordet in Bruxelles (Belgium).

Together, we talk about what will be the prostate cancer screening of the future:

• Which techniques?

• Which technologies?

• Which trends?

Hosted by Ausha. See ausha.co/privacy-policy for more information.